The Pandemic Darlings That Investors Are Souring On | Saxo Bank

The Pandemic Darlings That Investors Are Souring On | Saxo Bank

Saxo Stories 5 minutes to read

Summary:  During the pandemic lock down, the share price of so-called "pandemic darlings" were thriving. However, it seems that, for many of these companies, the party is over.


One of the most talked-about market trends of the pandemic was the astonishing rise of the share price of so-called "pandemic darlings" i.e. the companies that were best positioned to thrive in a world of working from home, ordering in, and pandemic-driven hobbies. There are plenty of examples that even the most casual investor can recall.

There were notable surges in many sectors, such as the share price growth of the e-conferencing platform Zoom in 2020, which became all the rage when companies across the world had to switch to remote meetings almost overnight. Then there are the record gains experienced by streaming giants such as Netflix, which saw its share price briefly hit $690 a share at the height of the pandemic streaming boom.

However, it seems that, for many of those pandemic darlings, the party is over. Around the world, people, businesses, and society are returning to normal, and those once-popular stocks are no longer in vogue. Let's take a closer look at the pandemic darlings that investors are no longer so hot on.

Covid Darlings: Biggest stock price drops pre and post pandemic

The streaming boom that wasn't

When looking at the pandemic darlings that have quickly shaped up to be post-pandemic losers, streaming services stand out more than almost any other sector. The case in point here is Zoom, which saw its stock close at a record high of $559 a share in October 2020 before dropping 74% to $143 in January 2022. The same can be seen among the TV streaming giants, with Netflix and Roku seeing their share price fall 44% and 68% respectively from their pandemic highs, as more and more of us returned to pre-pandemic lifestyles.

Covid Darlings: Software companies

The pandemic fad stocks that didn't hold

Some of the biggest stock market trends of the pandemic age cannot be divided neatly into sectors. If you recall, the past two years have seen several "fad" stocks that have seen record growth for a short time, before falling not long after.

Many examples are symptomatic of this pandemic-era investing mania that has since settled down. There's the Virgin Galactic stock, which soared to $55 a share in June 2020, before plummeting to just $8 a share by 2022, an 85% decrease.

And who can forget the enthusiasm for QuantumScape, the US company that researches lithium batteries for electric cars? In December 2020 alone, its share price tripled to $114 a share, before promptly falling a month later. More recently, the price reached $14.12 in January 2022, an 87% drop that makes this one of the worst performers of the entire pandemic era.

Covid Darlings: Top 10 Biggest Price Drops of Covid Darlings

Who needs a Peloton?

Of course, many of the biggest losers in society's gradual return to normal were those companies that profited in the early days of isolation and remote cocktail parties.

A standout example is the exercise bike company Peloton, which saw its share price skyrocket in the summer of 2020, but fell 85% through the course of 2021, as many realised they no longer needed indoor gym equipment as much as they thought.

Another parable for the post-pandemic era is the fall of Zillow's share price. The online house-hunting platform surged in popularity as millions of us spent the pandemic searching for greener pastures, only to lose 77% of its market cap in 2021, as the real estate boom fizzled out. 
Covid Darlings: Stock price drops in the entertainment and streaming industry

Methodology:

Please note stocks listed in this study have been commonly identified by media as companies whose stocks soared during 2020 and 2021 and which have since seen a dramatic drop in 2022. We have looked at Saxo Bank’s trading platform pricing data from January 2020 -Dec 2021 (pandemic), and January 2022 till 08/02/2022 (post-pandemic). 

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.